Genetic mutations have been reported to associate with ovarian cancer progression, such as BRCA1 (breast cancer 1) mutation and BRCA2 (breast cancer 2) mutation (Sanchez-Lorenzo et al., 2022). This evidence concerns the gene BRCA1 and breast carcinoma.